PET and SPECT in medically non-refractory complex partial seizures: Temporal asymmetries of glucose consumption, benzodiazepine receptor density, and blood flow

NuklearMedizin

Volumn 37, Issue 7, 1998, Pages 221-226

  Matheja, P ^a   Kuwert, T ^a   Stodieck, S R G ^a   Diehl, Beate ^a   Wolf, Kerstin ^a   Schuierer, G ^a   Ringelstein, E B ^a   Schober, O ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Focal epilepsy; PET; Regional cerebral benzodiazepine receptor density; Regional cerebral blood flow; Regional cerebral glucose consumption; SPECT

Indexed keywords

BENZODIAZEPINE RECEPTOR; CARBAMAZEPINE; CYSTEINE ETHYL ESTER TC 99M; FLUORODEOXYGLUCOSE F 18; IOMAZENIL I 123; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN METABOLISM; CLINICAL ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSITRON EMISSION TOMOGRAPHY; RADIOISOTOPE DISTRIBUTION; RECEPTOR DENSITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0031788884     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1632338     Document Type: Article

References (41)

1. Abou-Khalil BW, Siegel GJ, Sackellares JC, Gilman S, Hichwa R, Marshall R. Positron emission tomography studies of cerebral glucose metabolism in chronic partial epilepsy. Ann Neurol 1987; 22. 480-6.
2. Arnold S, Schlaug G, Niemann H et al. Topography of interictal glucose hypometabolism in unilateral mesiotemporal epilepsy. Neurology 1996; 46: 1422-30.
3. Bartenstein P, Ludolph A, Schober O et al. Benzodiazepine receptors and cerebral blood flow in partial epilepsy. Eur J Nucl Med 1991; 18: 111-8.
4. Chang L. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978; NS-26/2: 2780-9.
5. Cordes M, Christie W, Henkes H et al. Focal epilepsies: HM-PAO SPECT compared with CT, MR, and EEG. J Comput Assist Tomogr 1990; 14: 402-9.
6. Debets RM, Sadzot B, van Isselt JW et al. Is C-11-flumazenil PET superior to F-18-FDG PET and 123-I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy? J Neurol Neurosurg Psychiatry 1997; 62: 141-50.
7. Debets RM, van Veelen CW, Maquet P et al. Quantitative analysis of 18/FDG-PET in the presurgical evaluation of patients suffering from refractory partial epilepsy. Comparison with CT, MRI, and combined subdural and depth. EEG. Acta Neurochir Suppl 1990; 50: 88-94.
8. Duncan S, Gillen GJ, Brodie MJ. Lack of effect of concomitant clobazam on interictal 123-I-iomazenil SPECT. Epilepsy Res 1993; 15: 61-6.
9. Engel J, Jr., Kuhl DE, Phelps ME, Crandall PH. Comparative localization of epileptic foci in partial epilepsy by PCT and EEG. Ann Neurol 1982; 12: 529-37.
10. Ferstl FJ, Cordes M, Cordes I et al. 123-I-iomazeml-SPECT in patients with focal epilepsies - a comparative study with 99m-Tc-HMPAO-SPECT, CT and MR. Adv Exp Med Biol 1991; 287: 405-12.
11. Fink GR, Pawlik G, Stefan H, Pietrzyk U, Wienhard K, Heiss W-D. Temporal lobe epilepsy: evidence for interictal uncoupling of blood flow and glucose metabolism in temporomesial structures. J Neurol Sci 1996; 137: 28-34.
12. Gaillard WD, Bhatia S, Bookheimer SY. Fazilat S, Sato S, Theodore WH. FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy. Neurology 1995; 45: 123-6.
13. Gaillard WD, Zeffiro T, Fazilat S, DeCarli C, Theodore WH. Effect of valproate on cerebral metabolism and blood flow: an 18F-2-deoxyglucose and 15O water positron emission tomography study. Epilepsia 1996; 37: 515-21.
14. Grunwald F, Durwen HF, Bockisch A et al. Technetium-99m-HMPAO brain SPECT in medically intractable temporal lobe epilepsy: a postoperative evaluation. J Nucl Med 1991; 32. 388-94.
15. Grunwald F, Menzel C, Pavics L et al. Ictal and interictal brain SPECT imaging in epilepsy using technetium-99m-ECD. J Nucl Med 1994; 35: 1896-901.
16. Harnacher K, Coenen HH, Stöcklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27: 235-8.
17. Ho SS, Berkovic SF, Berlangieri SU et al. Comparison of ictal SPECT and interictal PET in the presurgical evaluation of temporal lobe epilepsy. Ann Neurol 1995; 37: 738-45.
18. Kurokawa K, Jibiki I, Matsuda H et al. Comparison of benzodiazepine receptor and regional cerebral blood flow imaging of epileptiform foci in hippocampal kindled rabbits: a study with in vivo double tracer autoradiography using 125-I-iomazenil and 99mTc-HMPAO. Brain Res 1994; 642: 303-10.
19. Kuwert T, Stodieck SR, Puskás C et al. Reduced GABAA receptor density contralateral to a potentially epileptogenic MRI abnormality in a patient with complex partial seizures Eur J Nucl Med 1996; 23: 95-8.
20. Leiderman DB, Balish M, Bromfield EB, Theodore WH. Effect of valproate on human cerebral glucose metabolism. Epilepsia 1991; 32: 417-22.
21. Markand ON, Salanova V, Worth R, Park HM, Wellman HN. Comparative study of interictal PET and ictal SPECT in complex partial seizures. Acta Neurol Scand 1997; 95: 129-36.
22. Mastin ST, Drane WE, Gilmore RL, et al. Prospective localization of epileptogenic foci: comparison of PET and SPECT with site of surgery and clinical outcome. Radiology 1996; 199: 375-80.
23. Matheja P, Diehl B, Kuwert T et al. Measurement of temporal asymmetries of glucose consumption using linear profiles: reproducibility and comparison with visual analysis. Nuklearmedizin 1998; 37: 43-8.
24. Pawlik G, Hoithoff VA, Kessler J et al. Positron emission tomography findings relevant to neurosurgery for epilepsy. Acta Neurochir Suppl 1990; 50: 84-7.
25. Quesney L, Risinger M, Shewmon A. Extracranial EEG Evaluation. In: Engel J Jr, (ed.). Surgical Treatment of the Epilepsies (2nd edition). New York: Raven Press, 1993: 173-95.
26. Savic I, Persson A, Roland P, Pauli S, Sedvall G, Widen L. In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet 1988; 2: 863-6.
27. Savic I, Svanborg E. Thorell JO. Cortical benzodiazepine receptor changes are related to frequency of partial seizures: a positron emission tomography study. Epilepsia 1996; 37: 236-44.
28. Sjöholm H, Rosén I, Elmqvist D. Role of I-123-Iomazenil SPECT imaging in drug resistant epilepsy with complex partial seizures. Acta Neurol Scand 1995; 92: 41-8.
29. Spencer SS. The relative contributions of MRI, SPECT, and PET imaging in epilepsy. Epilepsia 1994; 35 Suppl 6: S72-89.
30. Staedt J, Stoppe G, Kogler A, Steinhoff BJ. Changes of central benzodiazepine receptor density in the course of anticonvulsant treatment in temporal lobe epilepsy. Seizure 1995; 4: 49-52.
31. Stefan H, Pawlik G, Böcher-Schwarz HG et al. Functional and morphological abnormalities in temporal lobe epilepsy: a comparison of interictal and ictal EEG, CT, MRI, SPECT and PET. J Neurol 1987; 234: 377-84.
32. Swartz BE, Tomiyasu U, Delgado-Escueta AV, Mandelkern M, Khonsari A, Neuroimaging in temporal lobe epilepsy: test sensitivity and relationships to pathology and post-operative outcome. Epilepsia 1992; 33: 624-34.
33. Talairach J, Tournoux P (eds.). Co-Planar Stereotaxic Atlas of the Human Brain. Stuttgart: Thieme Medical Publishers, 1988.
34. Tanaka F, Yonekura Y, Ikeda A, et al. Presurgical identification of epileptic foci with iodine-123 iomazenil SPET: comparison with brain perfusion SPET and FDG PET. Eur J Nucl Med 1997; 24: 27-34.
35. Theodore WH. Antiepileptic drugs and cerebral glucose metabolism. Epilepsia 1988; 29 Suppl 2: S48-55.
36. Theodore WH, Katz D, Kufta C et al. Pathology of temporal lobe foci: correlation with CT, MRI, and PET. Neurology 1990; 40: 797-803.
37. Valk PE, Laxer KD, Barbaro NM, Knezevic S, Dillon WP, Budinger TF. High-resolution (2.6-mm) PET in partial complex epilepsy associated with mesial temporal sclerosis. Radiology 1993; 186: 55-8.
38. van Huffelen AC, van Isselt JW, van Veelen CW et al. Identification of the side of epileptic focus with 123-I-iomazenil SPECT. A comparison with F-18-FDG-PET and ictal EEG findings in patients with medically intractable complex partial seizures. Acta Neurochir Suppl 1990; 50: 95-9.
39. Venz S, Cordes M, Schmitz B et al. 123I-iomazenil- and 99m-Tc-HMPAO in the diagnosis of focal epilepsies: comparison of treated and untreated patients. Nuklearmedizin 1994; 33: 1-7.
40. Venz S, Cordes M, Straub HB, et al Preoperative evaluation of medically intractable partial seizures using 123-I-iomazenil SPECT. Comparison with video/EEG-monitoring and post-operative results. Nuklearmedizin 1994; 33: 189-93.
41. Woesler B, Kuwert T, Morgenroth C, et al. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123-I-α-methyl tyrosine and PET with F-18-deoxyglucose. Eur J Nucl Med 1997; 24: 428-34.